Mr. Zuckerberg also thinks the use of AWS is too high, he said: "One thing I'd like to say, take a look at our computational cost and our AWS bill. Let's call Jeff (the Amazon CEO, Jeff Bezos) and talk about it."
The CZI set up a number of projects involving cell biology, early cancer-related studies. Zuckerberg is selling shares to support the work of CZI. In addition, CZI co-operates with the biomedical research institute to set up the CZ-Bihoub (Chan Zuckerberg Biohb), the LinkedIn co-founder, Reid Hoffman, and other donors to donate funds to the CZ-Biohub.
In 2019, Zuckerberg listed some "personal challenges" for himself, including launching a series of discussions on the impact of future technology on society. Zuckerberg believes that there were three high costs in scientific research: recruiting staff for wet labs, manufacturing drugs, and clinical trials. Cost calculation has now become one of the top three costs. All large cloud providers believe that providing services to the biotechnology industry and supporting genetic projects is a good opportunity to make money.
In the last quarter, AWS's revenue grew to $8.4 billion; in July, Google said itCloud servicesAnnual revenue has reached $8 billion.Microsoftdidn't disclose Azure's revenue, but it ranked second in share after AWS.
The human genome is huge, made up of 6 billion base letters, and the data are huge, and scientists are trying to crack it. Joseph Drys (Joseph DeRisi), a biomolecologist at the University of California, points out that in developing countries, research institutions cannot afford high computing costs, which is a big challenge.